In the formal clinical trial reports for retatrutide, alopecia did not appear as a common side effect
Because of its powerful appetite-regulating effects, semaglutide is now widely used for medical weight management
Read more Insurance won't cover Ozempic for weight loss here's a path that doesn't need it BCBS of Illinois does not cover Ozempic for off-label weight loss and ACA plans administered by BCBS Illinois typically exclude GLP-1 weight-loss drugs entirely
Individuals with glutathione synthetase deficiency or on acetaminophen therapy should consult a provider before supplementation
But we can say that scientific opinion seems to lean more toward safe than unsafe. For example, in a 2021 Cognitive Vitality Report, the Alzheimers Drug Discovery Foundation points to a short-term study on CB4211 as some evidence for MOTS-cs safety.40 CB4211 is an analog, or synthetic version, of MOTS-c, and so it should theoretically pose a similar set of risks.41 The study in question was a double-blind, placebo-controlled trial in adult humans using both single doses and multiple ascending doses, under which protocol CB4211 was found to be safe and well tolerated.42 Side effects and potential health risks of MOTS-c Even if MOTS-c is as safe as CB4211, clinical researchers and the healthcare providers we know warn that it potentially poses specific health risks
James SJ, Cutler P, Melnyk S, et al
/assets/images/provider/photos/2775905.jpeg)
